Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yaling Hu

Showing results (11-20 of 64) with videos related to

Pageof 7
Sort By:
Plos One|November 4, 2021
Bioinformatics analysis of genes related to iron death in diabetic nephropathy through network and pathway levels based approachesYaling Hu, Shuang Liu, Wenyuan Liu, et al.
Medical Oncology (Northwood, London, England)|November 29, 2014
MicroRNA-204-5p inhibits gastric cancer cell proliferation by downregulating USP47 and RAB22ABinbin Zhang, Yuan Yin, Yaling Hu, et al.
DNA and Cell Biology|September 26, 2023
Astragaloside IV Inhibited Podocyte Pyroptosis in Diabetic Kidney Disease by Regulating SIRT6/HIF-1α AxisMingyu Zhang, Wenyuan Liu, Yuxiang Liu, et al.
Plos One|May 31, 2024
Astragaloside IV alleviates renal fibrosis by inhibiting renal tubular epithelial cell pyroptosis induced by urotensin II through regulating the cAMP/PKA signaling pathwayLin Zhang, Wenyuan Liu, Sufen Li, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 5, 2020
Neutralizing Antibody Responses to Severe Acute Respiratory Syndrome Coronavirus 2 in Coronavirus Disease 2019 Inpatients and Convalescent PatientsXiaoli Wang, Xianghua Guo, Qianqian Xin, et al.
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|April 5, 2022
Potential Molecular Mechanism of Yishen Capsule in the Treatment of Diabetic Nephropathy Based on Network Pharmacology and Molecular DockingYaling Hu, Shuang Liu, Wenyuan Liu, et al.
Pathology, Research and Practice|May 14, 2016
miR-139-5p sensitizes colorectal cancer cells to 5-fluorouracil by targeting NOTCH-1Heyong Liu, Yuan Yin, Yaling Hu, et al.
Glia|December 4, 2019
mTOR-mediated metabolic reprogramming shapes distinct microglia functions in response to lipopolysaccharide and ATPYaling Hu, Weihao Mai, Lunhao Chen, et al.
Frontiers in Immunology|October 6, 2023
Safety and immunogenicity of a modified Omicron-adapted inactivated vaccine in healthy adults: a randomized, double-blind, active-controlled Phase III clinical trialJialei Hu, Yueyue Liu, Shuo Liu, et al.
Pharmaceutics|January 25, 2025
Safety and Intranasal Retention of a Broad-Spectrum Anti-SARS-CoV-2 Monoclonal Antibody SA55 Nasal Spray in Healthy Volunteers: A Phase I Clinical TrialChaoying Hu, Yibo Zhou, Xing Meng, et al.
Pageof 7

Showing results (11-20 of 64) with videos related to

Sort By:
Pageof 7
Plos One|November 4, 2021
Bioinformatics analysis of genes related to iron death in diabetic nephropathy through network and pathway levels based approachesYaling Hu, Shuang Liu, Wenyuan Liu, et al.
Medical Oncology (Northwood, London, England)|November 29, 2014
MicroRNA-204-5p inhibits gastric cancer cell proliferation by downregulating USP47 and RAB22ABinbin Zhang, Yuan Yin, Yaling Hu, et al.
DNA and Cell Biology|September 26, 2023
Astragaloside IV Inhibited Podocyte Pyroptosis in Diabetic Kidney Disease by Regulating SIRT6/HIF-1α AxisMingyu Zhang, Wenyuan Liu, Yuxiang Liu, et al.
Plos One|May 31, 2024
Astragaloside IV alleviates renal fibrosis by inhibiting renal tubular epithelial cell pyroptosis induced by urotensin II through regulating the cAMP/PKA signaling pathwayLin Zhang, Wenyuan Liu, Sufen Li, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 5, 2020
Neutralizing Antibody Responses to Severe Acute Respiratory Syndrome Coronavirus 2 in Coronavirus Disease 2019 Inpatients and Convalescent PatientsXiaoli Wang, Xianghua Guo, Qianqian Xin, et al.
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|April 5, 2022
Potential Molecular Mechanism of Yishen Capsule in the Treatment of Diabetic Nephropathy Based on Network Pharmacology and Molecular DockingYaling Hu, Shuang Liu, Wenyuan Liu, et al.
Pathology, Research and Practice|May 14, 2016
miR-139-5p sensitizes colorectal cancer cells to 5-fluorouracil by targeting NOTCH-1Heyong Liu, Yuan Yin, Yaling Hu, et al.
Glia|December 4, 2019
mTOR-mediated metabolic reprogramming shapes distinct microglia functions in response to lipopolysaccharide and ATPYaling Hu, Weihao Mai, Lunhao Chen, et al.
Frontiers in Immunology|October 6, 2023
Safety and immunogenicity of a modified Omicron-adapted inactivated vaccine in healthy adults: a randomized, double-blind, active-controlled Phase III clinical trialJialei Hu, Yueyue Liu, Shuo Liu, et al.
Pharmaceutics|January 25, 2025
Safety and Intranasal Retention of a Broad-Spectrum Anti-SARS-CoV-2 Monoclonal Antibody SA55 Nasal Spray in Healthy Volunteers: A Phase I Clinical TrialChaoying Hu, Yibo Zhou, Xing Meng, et al.
Pageof 7